|
GERN
|
Geron Corporation
|
0.08%
|
US
|
NASDAQ
|
|
DAWN
|
Day One Biopharmaceuticals, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
ACRS
|
Aclaris Therapeutics, Inc.
|
0.08%
|
US
|
NASDAQ
|
|
BLU
|
BELLUS Health Inc.
|
0.08%
|
US
|
NASDAQ
|
|
VERV
|
Verve Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
PRVB
|
Provention Bio, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
PLRX
|
Pliant Therapeutics, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
KURA
|
Kura Oncology, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
IMGO
|
Imago BioSciences, Inc
|
0.07%
|
US
|
NASDAQ
|
|
IDYA
|
IDEAYA Biosciences, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
CRNX
|
Crinetics Pharmaceuticals, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
CHRS
|
Coherus BioSciences, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
BBIO
|
BridgeBio Pharma, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
0.07%
|
US
|
NASDAQ
|
|
ACLX
|
Arcellx, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
TBPH
|
Theravance Biopharma, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
STVN
|
Stevanato Group S.p.A
|
0.06%
|
US
|
NYSE
|
|
RAPT
|
RAPT Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
MRUS
|
Merus N.V.
|
0.06%
|
US
|
NASDAQ
|
|
INBX
|
Inhibrx, Inc.
|
0.06%
|
US
|
NASDAQ
|